Clinical Trials Directory

Trials / Unknown

UnknownNCT03300869

Natural History of Types 2 and 3 SMA in Taiwan

Natural History of Types 2 and 3 Spinal Muscular Atrophy in Taiwan

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital · Academic / Other
Sex
All
Age
6 Months – 70 Years
Healthy volunteers
Not accepted

Summary

The primary objective of this study is to investigate the natural history of spinal muscular atrophy (SMA) types 2 and 3 patients in Taiwan. This study will provide further insights into the clinical course SMA. Several analyses will be conducted regarding overall survival, demographic characteristics, motor function, respiratory and nutritional support, and genotype and phenotype correlation.

Detailed description

As with other rare diseases, individual groups of SMA have therefore opted to share patient information in the form of clinical sites to increase the overall patient cohorts on which clinical outcomes and new assisted-healthcare technologies can be assessed. Using the collaborative and retrospective study of types 2 and 3 SMA patients in Taiwan, the investigators aim to 1) characterize the correlation of genotype and phenotype, 2) correlate the onset, progression, management with disease outcome, 3) depict comorbidity and within type 2 and 3 SMA patients with different SMN2 copy number.

Conditions

Timeline

Start date
2017-09-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2017-10-04
Last updated
2019-07-26

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03300869. Inclusion in this directory is not an endorsement.